Contribution of platelet activation to plasma IL-18 concentrations in HIV-infected AIDS patients
- 11 September 2006
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 20 (14), 1907-1909
- https://doi.org/10.1097/01.aids.0000244217.46445.45
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patientsClinical and Experimental Immunology, 2003
- Elevated Levels of Circulating Interleukin-18 in Human Immunodeficiency Virus-Infected Individuals: Role of Peripheral Blood Mononuclear Cells and Implications for AIDS PathogenesisJournal of Virology, 2002
- Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieuCytokine & Growth Factor Reviews, 2001
- Activated human platelets express Fas-L and induce apoptosis in Fas-positive tumor cellsJournal of Leukocyte Biology, 2001
- IL-18 underexpression reduces IL-2 levels during HIV infection: a critical step towards the faulty cell-mediated immunity?AIDS, 2000
- GPV Is a Marker of In Vivo Platelet Activation – Study in a Rat Thrombosis ModelThrombosis and Haemostasis, 2000
- IL-18: A TH1 -inducing, proinflammatory cytokine and new member of the IL-1 familyJournal of Allergy and Clinical Immunology, 1999
- Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infectionThe FASEB Journal, 1998
- Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane.Journal of Biological Chemistry, 1992